Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07675967 · ClinicalTrials.gov registry record
Clonal Hematopoiesis Chemotherapy and Radiation Effects Study
A clinical trial, sponsored by Dana-Farber Cancer Institute.
- Recruiting
- Registry status
- 5,000
- Enrollment target
NCT07675967 is a clinical trial that is actively recruiting participants, run by Dana-Farber Cancer Institute. The registered enrollment target is 5,000 participants.
The verdict
NCT07675967 is actively recruiting participants, sponsored by Dana-Farber Cancer Institute.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
Study Summary
The goal of the Clonal Hematopoiesis Chemotherapy and Radiation Effects (CH CARE) Study is to understand how the presence or absence of clonal hematopoiesis (CH) influences outcomes in people receiving chemotherapy and radiation for solid cancers. The study will collect biospecimens and clinical information. These data will be used to define clinical and molecular features that predict the presence of high-risk clonal hematopoiesis (CH) in patients exposed to cytotoxic anti-cancer therapy. Predictive features will be utilized to identify populations of cancer patients and survivors who are at the highest risk of developing therapy-related myeloid neoplasms (t-MNs). Ultimately this study will result in the development of a novel novel risk prediction algorithm for t-MNs in patients with solid cancers and drive potential therapeutic approaches to intercept progression from CH to often fatal t-MNs.
Interventions
- OTHER Samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2025-04-04 |
| Est. Completion | 2035-03-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07675967
The ClinicalTrials.gov registry entry for NCT07675967 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 5,000 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Samples is the first listed.
NCT07675967 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07675967 about?
NCT07675967 is a clinical study titled "Clonal Hematopoiesis Chemotherapy and Radiation Effects Study". The goal of the Clonal Hematopoiesis Chemotherapy and Radiation Effects (CH CARE) Study is to understand how the presence or absence of clonal hematopoiesis (CH) influences outcomes in people receiving chemotherapy and radiation for solid cancers. The study will collect biospecimens and clinical in...
What is the current status of trial NCT07675967?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2025-04-04. Estimated completion is 2035-03-31.
What interventions are being tested in trial NCT07675967?
The interventions under investigation include: Samples (OTHER).
Who is sponsoring clinical trial NCT07675967?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.